CompletedPHASE1, PHASE2NCT00305708

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

Studying Diamond-Blackfan anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Morton J. Cowan, MD
University of California, San Francisco
Intervention
anti-thymocyte globulin(biological)
Enrollment
40 enrolled
Eligibility
17 years · All sexes
Timeline
2000 – 2004

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00305708 on ClinicalTrials.gov

Other trials for Diamond-Blackfan anemia

Additional recruiting or active studies for the same condition.

See all trials for Diamond-Blackfan anemia →

← Back to all trials